NDC 86211-114-01 - Methocarbamol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 86211-114
- Requested NDC
- 86211-114-01
- Package NDCs from labels
- 86211-114-01, 86211-114-10
- Manufacturer
- JVET PHARMACEUTICALS LLC | Gland Pharma Limited
- Effective date
- 2026-05-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Methocarbamol - JVET PHARMACEUTICALS LLC | Gland Pharma Limited | JVET PHARMACEUTICALS LLC | Gland Pharma Limited | 2026-05-22 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 86211-114-01 | Methocarbamol | 10 mL in 1 VIAL | INJECTION | 10 | 1 | |
| 86211-114-10 | Methocarbamol | 10 in 1 CARTON | INJECTION | 10 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methocarbamol | METHOCARBAMOL | Bryant Ranch Prepack | b72a3fff-9710-4c60-8ca6-ed428377fc24 | 2026-03-16 | Warnings, Adverse reactions | 125OD7737X |
| ATMEKSI | METHOCARBAMOL | Rosemont Pharmaceuticals LLC | 62de7345-613b-4838-96e5-aceca3cea6b2 | 2026-03-13 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | Advanced Rx of Tennessee, LLC | 4cefe51c-d824-a862-e063-6394a90a7717 | 2026-03-13 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bryant Ranch Prepack | d3448618-c9b4-4cb9-a30e-1afc8197cfe1 | 2026-03-11 | Warnings, Adverse reactions | 125OD7737X |
| Skin Irritations and Itch Relief | AGARICUS MUSCARIUS, ALUMINA, ANAGALLIS ARVENSIS, ANTIMONIUM TARTARICUM, APIS MELLIFICA, ARSENICUM ALBUM, ARSENICUM IODATUM, BOVISTA, CAUSTICUM, DOLICHOS PRURIENS, FAGOPYRUM ESCULENTUM, GRAPHITES, KALI MURIATICUM, MURIATICUM ACIDUM, OLEANDER, PETROLEUM, PIX LIQUIDA, RADIUM BROMATUM (12X, 30X, 1LM), RHUS TOX, SELENIUM METALLICUM, SULPHUR AND URTICA URENS. | King Bio Inc. | d139d2f1-0369-4963-9f3d-c4cc0f1ea2dd | 2026-03-10 | Warnings | QTT17582CB |
| 2-Pack Facial Serum | 2-PACK FACIAL SERUM | Guangzhou Ariel Biotech Co., Ltd. | 27c7f645-cfb3-6db1-e063-6394a90a42ff | 2026-03-06 | Warnings | 059QF0KO0R |
| Methocarbamol | METHOCARBAMOL TABLETS | Redpharm Drug | 44f264fd-bf40-bed9-e063-6294a90ac44a | 2026-03-05 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Proficient Rx LP | 311c79a5-1447-4fef-8726-ae003ef64db5 | 2026-03-01 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Advanced Rx of Tennessee, LLC | 4b1d8ac6-d25d-1c37-e063-6394a90aba29 | 2026-02-18 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 288a3bcd-a2c8-4a9b-9602-59c0493b4a8d | 2026-02-16 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 3b0e60a7-3cff-4665-a473-ad3257619cdd | 2026-02-16 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 943fe701-5d7d-4abe-a529-c5a548e94bc6 | 2026-02-16 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 440bf1ba-a704-4c35-bece-0a0987fc0c11 | 2026-02-16 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 12c8da39-3a0e-4303-9655-29dd83507837 | 2026-02-16 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PHOENIX RX LLC | 4abc29e9-a0cc-06cf-e063-6294a90ad874 | 2026-02-13 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Major Pharmaceuticals | 2df34fa7-9cdc-4be4-ac6f-577122462606 | 2026-02-10 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bostal LLC | d8f10211-f96e-4cf3-9b49-986eb51b703d | 2026-02-04 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | NuCare Pharmaceuticals,Inc. | 72f36d28-15d2-30f6-e053-2a91aa0ad1ce | 2026-01-30 | Warnings, Adverse reactions | 125OD7737X |
| INSULIN DILUTING MEDIUM FOR Kirsty | WATER | Biocon Biologics Inc. | 3db1d482-7e1f-aec6-79ef-3f305b4d8277 | 2026-01-20 | Warnings, Adverse reactions | 059QF0KO0R |
| Methocarbamol | METHOCARBAMOL | UNICHEM PHARMACEUTICALS (USA), INC. | 5777cbb0-b5fd-4b36-ac1d-bc105fe96888 | 2026-01-19 | Warnings, Adverse reactions | 125OD7737X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.